MX2015011359A - Inhibidores macrociclicos de cinasa 2 de repeticion rica en leucina (lrrk2). - Google Patents
Inhibidores macrociclicos de cinasa 2 de repeticion rica en leucina (lrrk2).Info
- Publication number
- MX2015011359A MX2015011359A MX2015011359A MX2015011359A MX2015011359A MX 2015011359 A MX2015011359 A MX 2015011359A MX 2015011359 A MX2015011359 A MX 2015011359A MX 2015011359 A MX2015011359 A MX 2015011359A MX 2015011359 A MX2015011359 A MX 2015011359A
- Authority
- MX
- Mexico
- Prior art keywords
- kinase inhibitors
- compounds
- present
- lrrk2 kinase
- macrocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La presente invención se refiere a compuestos macrocíclicos y a las composiciones que contienen los compuestos, que actúan como inhibidores de la cinasa, en particular como inhibidores de la cinasa de LRRIK2, para usarse en el diagnóstico, prevención y/o tratamiento de las enfermedades asociadas con la cinasa de LRRK2. Además, la presente invención proporciona métodos de uso de los compuestos, por ejemplo como un agente medicinal o de diagnóstico. Finalmente, la presente invención también se refiere a nuevos compuesto macrocíclicos.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13305311 | 2013-03-15 | ||
| EP13305314 | 2013-03-15 | ||
| PCT/EP2014/055049 WO2014140235A1 (en) | 2013-03-15 | 2014-03-14 | Macrocyclic lrrk2 kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015011359A true MX2015011359A (es) | 2015-12-16 |
Family
ID=50277239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015011359A MX2015011359A (es) | 2013-03-15 | 2014-03-14 | Inhibidores macrociclicos de cinasa 2 de repeticion rica en leucina (lrrk2). |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20160031905A1 (es) |
| EP (1) | EP2970333B1 (es) |
| JP (1) | JP2016510793A (es) |
| KR (1) | KR20150129016A (es) |
| CN (1) | CN105143232A (es) |
| AU (1) | AU2014230485A1 (es) |
| BR (1) | BR112015019873A2 (es) |
| CA (1) | CA2904462A1 (es) |
| DK (1) | DK2970333T3 (es) |
| EA (1) | EA201591698A1 (es) |
| ES (1) | ES2635021T3 (es) |
| HK (1) | HK1219481A1 (es) |
| MX (1) | MX2015011359A (es) |
| PL (1) | PL2970333T3 (es) |
| PT (1) | PT2970333T (es) |
| SG (1) | SG11201506357RA (es) |
| TW (1) | TW201444850A (es) |
| WO (1) | WO2014140235A1 (es) |
| ZA (1) | ZA201506327B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201507594YA (en) * | 2013-03-15 | 2015-10-29 | Oncodesign Sa | Macrocyclic rip2 kinase inhibitors |
| WO2016146651A1 (en) | 2015-03-16 | 2016-09-22 | Oncodesign Sa | Macrocyclic activin-like receptor kinase inhibitors |
| WO2019201131A1 (zh) * | 2018-04-16 | 2019-10-24 | 深圳市塔吉瑞生物医药有限公司 | 用于抑制蛋白激酶活性的二(杂)芳基大环化合物 |
| CN115698020A (zh) * | 2020-01-31 | 2023-02-03 | 昂科迪塞恩精密医药公司(Opm) | 大环rip2-激酶抑制剂 |
| US11858940B2 (en) * | 2020-03-21 | 2024-01-02 | Arvinas Operations, Inc. | Selective modulators of mutant LRRK2 proteolysis and associated methods of use |
| AR127470A1 (es) | 2021-10-27 | 2024-01-31 | H Lundbeck As | Inhibidores de lrrk2 |
| CN117425660A (zh) * | 2022-05-18 | 2024-01-19 | 上海翊石医药科技有限公司 | 一种芳杂环类化合物及其中间体、药物组合物和用途 |
| CN117659043A (zh) * | 2022-09-07 | 2024-03-08 | 苏州朗睿生物医药有限公司 | 一种大环咪唑并[1,2-b]哒嗪衍生物及其制备方法和用途 |
| US11958865B1 (en) | 2022-09-15 | 2024-04-16 | H. Lundbeck A/S | Leucine-rich repeat kinase 2 (LRRK2) inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201008134D0 (en) * | 2010-05-14 | 2010-06-30 | Medical Res Council Technology | Compounds |
| GB201015949D0 (en) * | 2010-09-22 | 2010-11-03 | Medical Res Council Technology | Compounds |
| US9499535B2 (en) * | 2011-04-21 | 2016-11-22 | Origenis Gmbh | Kinase inhibitors |
| WO2013001310A1 (en) * | 2011-06-30 | 2013-01-03 | Centro Nacional De Investigaciones Oncológicas (Cnio) | Macrocyclic compounds and their use as cdk8 inhibitors |
| MX342177B (es) * | 2011-09-30 | 2016-09-20 | Ipsen Pharma Sas | Inhibidores de cinasa 2 de repeticion rica en leucina (lrrk2) macrociclica. |
| CN103930427B (zh) * | 2011-09-30 | 2016-03-09 | 昂科迪塞恩股份有限公司 | 大环flt3激酶抑制剂 |
-
2014
- 2014-03-14 MX MX2015011359A patent/MX2015011359A/es unknown
- 2014-03-14 CN CN201480014168.6A patent/CN105143232A/zh active Pending
- 2014-03-14 CA CA2904462A patent/CA2904462A1/en not_active Abandoned
- 2014-03-14 TW TW103109451A patent/TW201444850A/zh unknown
- 2014-03-14 PT PT147099626T patent/PT2970333T/pt unknown
- 2014-03-14 WO PCT/EP2014/055049 patent/WO2014140235A1/en active Application Filing
- 2014-03-14 ES ES14709962.6T patent/ES2635021T3/es active Active
- 2014-03-14 EA EA201591698A patent/EA201591698A1/ru unknown
- 2014-03-14 PL PL14709962T patent/PL2970333T3/pl unknown
- 2014-03-14 KR KR1020157029380A patent/KR20150129016A/ko not_active Application Discontinuation
- 2014-03-14 JP JP2015562173A patent/JP2016510793A/ja not_active Abandoned
- 2014-03-14 DK DK14709962.6T patent/DK2970333T3/en active
- 2014-03-14 BR BR112015019873A patent/BR112015019873A2/pt not_active IP Right Cessation
- 2014-03-14 US US14/777,495 patent/US20160031905A1/en not_active Abandoned
- 2014-03-14 AU AU2014230485A patent/AU2014230485A1/en not_active Abandoned
- 2014-03-14 EP EP14709962.6A patent/EP2970333B1/en active Active
- 2014-03-14 SG SG11201506357RA patent/SG11201506357RA/en unknown
-
2015
- 2015-08-28 ZA ZA2015/06327A patent/ZA201506327B/en unknown
-
2016
- 2016-06-28 HK HK16107521.5A patent/HK1219481A1/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016510793A (ja) | 2016-04-11 |
| EA201591698A1 (ru) | 2016-02-29 |
| EP2970333A1 (en) | 2016-01-20 |
| AU2014230485A1 (en) | 2015-09-24 |
| BR112015019873A2 (pt) | 2017-07-18 |
| TW201444850A (zh) | 2014-12-01 |
| HK1219481A1 (zh) | 2017-04-07 |
| KR20150129016A (ko) | 2015-11-18 |
| EP2970333B1 (en) | 2017-05-03 |
| CN105143232A (zh) | 2015-12-09 |
| CA2904462A1 (en) | 2014-09-18 |
| US20160031905A1 (en) | 2016-02-04 |
| WO2014140235A1 (en) | 2014-09-18 |
| PL2970333T3 (pl) | 2017-12-29 |
| SG11201506357RA (en) | 2015-09-29 |
| DK2970333T3 (en) | 2017-08-21 |
| ES2635021T3 (es) | 2017-10-02 |
| ZA201506327B (en) | 2017-02-22 |
| PT2970333T (pt) | 2017-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015011359A (es) | Inhibidores macrociclicos de cinasa 2 de repeticion rica en leucina (lrrk2). | |
| PH12017501306A1 (en) | Inhibitors of histone demethylases | |
| MX2020010535A (es) | Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide. | |
| MX2015012528A (es) | Inhibidores macrociclicos de cinasa inducibles por sal. | |
| MX2019001125A (es) | Inhibidores de cinasa macrociclica. | |
| MX2015012526A (es) | Inhibodores macrociclicos de cinasa rip2. | |
| IN2015DN01156A (es) | ||
| SG10201808102WA (en) | Bicyclic heterocycle compounds and their uses in therapy | |
| PH12017500453A1 (en) | Spirocyclic inhibitors of cathepsin c | |
| PH12016502355B1 (en) | Pharmaceutical composition | |
| MX366899B (es) | Nuevos compuestos. | |
| MX349004B (es) | Nuevos compuestos. | |
| PH12016502291A1 (en) | Indolizine derivatives as phosphoinositide 3-kinases inhibitors | |
| MY181602A (en) | Isochromene derivatives as phosphoinositide 3-kinases inhibitors | |
| IN2015DN01151A (es) | ||
| PH12016500140A1 (en) | Heterobicycloaryl rorc2 inhibitors and methods of use thereof | |
| PH12016502352A1 (en) | Pharmaceutical composition | |
| TW201613578A (en) | Pharmaceutical combinations | |
| EA032271B9 (ru) | Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний | |
| MY186523A (en) | Macrocyclic rip2 kinase inhibitors | |
| MX2015013755A (es) | Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis. | |
| MX2015001648A (es) | Composiciones que comprenden derivados de espicamicina y metodos de uso de los mismos. | |
| SA515360233B1 (ar) | مثبطات إنزيمات هستون ديميثيلاز |